{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:43:54Z","timestamp":1793094234731,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["17MCPRP33670415"],"award-info":[{"award-number":["17MCPRP33670415"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["18CDA34110245"],"award-info":[{"award-number":["18CDA34110245"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003718","name":"Korea Institute of Oriental Medicine","doi-asserted-by":"crossref","award":["K18190"],"award-info":[{"award-number":["K18190"]}],"id":[{"id":"10.13039\/501100003718","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12265-019-09896-z","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T15:02:50Z","timestamp":1562338970000},"page":"569-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Application of Proteomics Profiling for Biomarker Discovery in Hypertrophic Cardiomyopathy"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3494-307X","authenticated-orcid":false,"given":"Yuichi J.","family":"Shimada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Kochav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Mohajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeyoun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muredach P.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Fifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"9896_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","volume":"92","author":"BJ Maron","year":"1995","unstructured":"Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T. T., & Bild, D. E. (1995). Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (Young) Adults. Circulation, 92, 785\u2013789.","journal-title":"Circulation"},{"key":"9896_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2261-14-36","volume":"14","author":"JD Marsiglia","year":"2014","unstructured":"Marsiglia, J. D., Credidio, F. L., de Oliveira, T. G., Reis, R. F., Antunes, M. O., de Araujo, A. Q., et al. (2014). Clinical predictors of a positive genetic test in hypertrophic cardiomyopathy in the Brazilian population. BMC Cardiovascular Disorders, 14, 36.","journal-title":"BMC Cardiovascular Disorders"},{"key":"9896_CR3","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1073\/pnas.1507719112","volume":"112","author":"Y Hathout","year":"2015","unstructured":"Hathout, Y., Brody, E., Clemens, P. R., Cripe, L., DeLisle, R. K., Furlong, P., et al. (2015). Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America, 112, 7153\u20137158.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9896_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3233\/JAD-130380","volume":"38","author":"SJ Kiddle","year":"2014","unstructured":"Kiddle, S. J., Sattlecker, M., Proitsi, P., Simmons, A., Westman, E., Bazenet, C., et al. (2014). Candidate blood proteome markers of Alzheimer\u2019s disease onset and progression: a systematic review and replication study. Journal of Alzheimer's Disease, 38, 515\u2013531.","journal-title":"Journal of Alzheimer's Disease"},{"key":"9896_CR5","doi-asserted-by":"publisher","first-page":"e0153674","DOI":"10.1371\/journal.pone.0153674","volume":"11","author":"T Marion","year":"2016","unstructured":"Marion, T., Elbahesh, H., Thomas, P. G., DeVincenzo, J. P., Webby, R., & Schughart, K. (2016). Respiratory mucosal proteome quantification in human influenza infections. PLoS One, 11, e0153674.","journal-title":"PLoS One"},{"key":"9896_CR6","doi-asserted-by":"publisher","first-page":"e35157","DOI":"10.1371\/journal.pone.0035157","volume":"7","author":"MR Mehan","year":"2012","unstructured":"Mehan, M. R., Ayers, D., Thirstrup, D., Xiong, W., Ostroff, R. M., Brody, E. N., et al. (2012). Protein signature of lung cancer tissues. PLoS One, 7, e35157.","journal-title":"PLoS One"},{"key":"9896_CR7","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1074\/mcp.M113.032136","volume":"13","author":"J Webber","year":"2014","unstructured":"Webber, J., Stone, T. C., Katilius, E., Smith, B. C., Gordon, B., Mason, M. D., et al. (2014). Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan) platform. Molecular & Cellular Proteomics, 13, 1050\u20131064.","journal-title":"Molecular & Cellular Proteomics"},{"key":"9896_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.tube.2014.01.006","volume":"94","author":"P Nahid","year":"2014","unstructured":"Nahid, P., Bliven-Sizemore, E., Jarlsberg, L. G., De Groote, M. A., Johnson, J. L., Muzanyi, G., et al. (2014). Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis. Tuberculosis, 94, 187\u2013196.","journal-title":"Tuberculosis"},{"key":"9896_CR9","unstructured":"McArdle, A., Butt, A. Q., Szentpetery, A., de Jager, W., de Roock, S., FitzGerald, O., et al. (2015). Developing clinically relevant biomarkers in inflammatory arthritis: a multi-platform approach for serum candidate protein discovery. Proteomics. Clinical Applications."},{"key":"9896_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.116.021803","volume":"134","author":"D Ngo","year":"2016","unstructured":"Ngo, D., Sinha, S., Shen, D., Kuhn, E., Keyes, M., Shi, X., et al. (2016). Aptamer-based proteomic profiling reveals novel candidate biomarkers and pathways in cardiovascular disease. Circulation, 134, 270\u2013285.","journal-title":"Circulation"},{"key":"9896_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCRESAHA.110.223834","volume":"108","author":"CE Seidman","year":"2011","unstructured":"Seidman, C. E., & Seidman, J. G. (2011). Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circulation Research, 108, 743\u2013750.","journal-title":"Circulation Research"},{"key":"9896_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa1002659","volume":"363","author":"CY Ho","year":"2010","unstructured":"Ho, C. Y., Lopez, B., Coelho-Filho, O. R., Lakdawala, N. K., Cirino, A. L., Jarolim, P., et al. (2010). Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. NEJM, 363, 552\u2013563.","journal-title":"NEJM"},{"key":"9896_CR13","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"BJ Gersh","year":"2011","unstructured":"Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., et al. (2011). 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 58, e212\u2013e260.","journal-title":"Journal of the American College of Cardiology"},{"key":"9896_CR14","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1253\/circj.CJ-17-0959","volume":"82","author":"SA McCullough","year":"2018","unstructured":"McCullough, S. A., Fifer, M. A., Mohajer, P., Lowry, P. A., Reen, C. O., Baggish, A. L., et al. (2018). Clinical correlates and prognostic value of elevated right atrial pressure in patients with hypertrophic cardiomyopathy. Circulation Journal, 82, 1405\u20131411.","journal-title":"Circulation Journal"},{"key":"9896_CR15","unstructured":"Hensley, P. (2013). SOMAmers and SOMAscan \u2013 a protein biomarker discovery platform for rapid analysis of sample collections from bench top to the clinic. Journal of Biomolecular Techniques, S5."},{"key":"9896_CR16","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., et al. (2010). Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One, 5, e15004.","journal-title":"PLoS One"},{"key":"9896_CR17","doi-asserted-by":"publisher","first-page":"e26332","DOI":"10.1371\/journal.pone.0026332","volume":"6","author":"S Kraemer","year":"2011","unstructured":"Kraemer, S., Vaught, J. D., Bock, C., Gold, L., Katilius, E., Keeney, T. R., et al. (2011). From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay. PLoS One, 6, e26332.","journal-title":"PLoS One"},{"key":"9896_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1471-2105-12-253","volume":"12","author":"KA Le Cao","year":"2011","unstructured":"Le Cao, K. A., Boitard, S., & Besse, P. (2011). Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems. BMC Bioinformatics, 12, 253.","journal-title":"BMC Bioinformatics"},{"key":"9896_CR19","first-page":"92","volume":"1","author":"B Worley","year":"2013","unstructured":"Worley, B., & Powers, R. (2013). Multivariate analysis in metabolomics. Current Metabolomics, 1, 92\u2013107.","journal-title":"Current Metabolomics"},{"key":"9896_CR20","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk, D., Morris, J. H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., et al. (2017). The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Research, 45, D362\u2013D368.","journal-title":"Nucleic Acids Research"},{"key":"9896_CR21","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1093\/bioinformatics\/bti448","volume":"21","author":"Y Pawitan","year":"2005","unstructured":"Pawitan, Y., Michiels, S., Koscielny, S., Gusnanto, A., & Ploner, A. (2005). False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics, 21, 3017\u20133024.","journal-title":"Bioinformatics"},{"key":"9896_CR22","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong, J., Soufan, O., Li, C., Caraus, I., Li, S., Bourque, G., et al. (2018). MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Research, 46, W486\u2013W494.","journal-title":"Nucleic Acids Research"},{"key":"9896_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/07853890.2013.792555","volume":"45","author":"E Orenes-Pinero","year":"2013","unstructured":"Orenes-Pinero, E., Hernandez-Romero, D., de Torre, C., Vilchez, J. A., Martinez, M., Romero-Aniorte, A. I., et al. (2013). Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches. Annals of Medicine, 45, 341\u2013347.","journal-title":"Annals of Medicine"},{"key":"9896_CR24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.33549\/physiolres.933253","volume":"65","author":"H Rehulkova","year":"2016","unstructured":"Rehulkova, H., Rehulka, P., Myslivcova Fucikova, A., Stulik, J., & Pudil, R. (2016). Identification of novel biomarker candidates for hypertrophic cardiomyopathy and other cardiovascular diseases leading to heart failure. Physiological Research, 65, 751\u2013762.","journal-title":"Physiological Research"},{"key":"9896_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jjcc.2015.05.005","volume":"67","author":"T Kubo","year":"2016","unstructured":"Kubo, T., Okumiya, T., Baba, Y., Hirota, T., Tanioka, K., Yamasaki, N., et al. (2016). Erythrocyte creatine as a marker of intravascular hemolysis due to left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Journal of Cardiology, 67, 274\u2013278.","journal-title":"Journal of Cardiology"},{"key":"9896_CR26","doi-asserted-by":"publisher","first-page":"9470","DOI":"10.1073\/pnas.1633695100","volume":"100","author":"Y Kawakami","year":"2003","unstructured":"Kawakami, Y., Kitaura, J., Yao, L., McHenry, R. W., Kawakami, Y., Newton, A. C., et al. (2003). A Ras activation pathway dependent on Syk phosphorylation of protein kinase C. Proceedings of the National Academy of Sciences of the United States of America, 100, 9470\u20139475.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9896_CR27","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1016\/S0021-9258(18)41866-2","volume":"267","author":"N Goode","year":"1992","unstructured":"Goode, N., Hughes, K., Woodgett, J. R., & Parker, P. J. (1992). Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. The Journal of Biological Chemistry, 267, 16878\u201316882.","journal-title":"The Journal of Biological Chemistry"},{"key":"9896_CR28","doi-asserted-by":"publisher","first-page":"18848","DOI":"10.1074\/jbc.M116.773713","volume":"292","author":"D Shen","year":"2017","unstructured":"Shen, D., Podolnikova, N. P., Yakubenko, V. P., Ardell, C. L., Balabiyev, A., Ugarova, T. P., et al. (2017). Pleiotrophin, a multifunctional cytokine and growth factor, induces leukocyte responses through the integrin mac-1. The Journal of Biological Chemistry, 292, 18848\u201318861.","journal-title":"The Journal of Biological Chemistry"},{"key":"9896_CR29","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/bph.12353","volume":"171","author":"T Muramatsu","year":"2014","unstructured":"Muramatsu, T. (2014). Structure and function of midkine as the basis of its pharmacological effects. British Journal of Pharmacology, 171, 814\u2013826.","journal-title":"British Journal of Pharmacology"},{"key":"9896_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nature12308","volume":"499","author":"Y Zheng","year":"2013","unstructured":"Zheng, Y., Zhang, C., Croucher, D. R., Soliman, M. A., St-Denis, N., Pasculescu, A., et al. (2013). Temporal regulation of EGF signalling networks by the scaffold protein Shc1. Nature, 499, 166\u2013171.","journal-title":"Nature"},{"key":"9896_CR31","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1046\/j.1432-1327.2001.02230.x","volume":"268","author":"C Giglione","year":"2001","unstructured":"Giglione, C., Gonfloni, S., & Parmeggiani, A. (2001). Differential actions of p60c-Src and Lck kinases on the Ras regulators p120-GAP and GDP\/GTP exchange factor CDC25Mm. European Journal of Biochemistry, 268, 3275\u20133283.","journal-title":"European Journal of Biochemistry"},{"key":"9896_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1161\/HYPERTENSIONAHA.109.138636","volume":"55","author":"T Kishi","year":"2010","unstructured":"Kishi, T., Hirooka, Y., Konno, S., Ogawa, K., & Sunagawa, K. (2010). Angiotensin II type 1 receptor-activated caspase-3 through ras\/mitogen-activated protein kinase\/extracellular signal-regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats. Hypertension, 55, 291\u2013297.","journal-title":"Hypertension"},{"key":"9896_CR33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.molcel.2012.09.028","volume":"48","author":"W Yang","year":"2012","unstructured":"Yang, W., Xia, Y., Cao, Y., Zheng, Y., Bu, W., Zhang, L., et al. (2012). EGFR-induced and PKCepsilon monoubiquitylation-dependent NF-kappaB activation upregulates PKM2 expression and promotes tumorigenesis. Molecular Cell, 48, 771\u2013784.","journal-title":"Molecular Cell"},{"key":"9896_CR34","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1172\/JCI44929","volume":"121","author":"X Wu","year":"2011","unstructured":"Wu, X., Simpson, J., Hong, J. H., Kim, K. H., Thavarajah, N. K., Backx, P. H., et al. (2011). MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation. The Journal of Clinical Investigation, 121, 1009\u20131025.","journal-title":"The Journal of Clinical Investigation"},{"key":"9896_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ng1748","volume":"38","author":"S Schubbert","year":"2006","unstructured":"Schubbert, S., Zenker, M., Rowe, S. L., Boll, S., Klein, C., Bollag, G., et al. (2006). Germline KRAS mutations cause Noonan syndrome. Nature Genetics, 38, 331\u2013336.","journal-title":"Nature Genetics"},{"key":"9896_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ng2073","volume":"39","author":"B Pandit","year":"2007","unstructured":"Pandit, B., Sarkozy, A., Pennacchio, L. A., Carta, C., Oishi, K., Martinelli, S., et al. (2007). Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nature Genetics, 39, 1007\u20131012.","journal-title":"Nature Genetics"},{"key":"9896_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","volume":"14","author":"KA Rauen","year":"2013","unstructured":"Rauen, K. A. (2013). The RASopathies. Annual Review of Genomics and Human Genetics, 14, 355\u2013369.","journal-title":"Annual Review of Genomics and Human Genetics"},{"key":"9896_CR38","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1093\/cvr\/cvx183","volume":"113","author":"KC Park","year":"2017","unstructured":"Park, K. C., Gaze, D. C., Collinson, P. O., & Marber, M. S. (2017). Cardiac troponins: from myocardial infarction to chronic disease. Cardiovascular Research, 113, 1708\u20131718.","journal-title":"Cardiovascular Research"},{"key":"9896_CR39","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1161\/01.CIR.0000121426.43044.2B","volume":"109","author":"N Tsybouleva","year":"2004","unstructured":"Tsybouleva, N., Zhang, L., Chen, S., Patel, R., Lutucuta, S., Nemoto, S., et al. (2004). Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation, 109, 1284\u20131291.","journal-title":"Circulation"},{"key":"9896_CR40","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40336-015-0133-z","volume":"3","author":"DO Verschure","year":"2015","unstructured":"Verschure, D. O., van Eck-Smit, B. L., Somsen, G. A., & Verberne, H. J. (2015). Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy. Clinical and Translational Imaging, 3, 379\u2013385.","journal-title":"Clinical and Translational Imaging"},{"key":"9896_CR41","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1021\/pr200612y","volume":"11","author":"BR Wei","year":"2012","unstructured":"Wei, B. R., Simpson, R. M., Johann, D. J., Dwyer, J. E., Prieto, D. A., Kumar, M., et al. (2012). Proteomic profiling of H-Ras-G12V induced hypertrophic cardiomyopathy in transgenic mice using comparative LC-MS analysis of thin fresh-frozen tissue sections. Journal of Proteome Research, 11, 1561\u20131570.","journal-title":"Journal of Proteome Research"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-019-09896-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12265-019-09896-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-019-09896-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T05:35:35Z","timestamp":1610256935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12265-019-09896-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9896"],"URL":"https:\/\/doi.org\/10.1007\/s12265-019-09896-z","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"23 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Fifer is a consultant to and scientific advisory board member of MyoKardia. The other authors have no conflict of interest related to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Subjects\/Informed Consent Statement"}},{"value":"No animal studies were carried out by the authors for this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Studies"}}]}}